NRC Health Fair Value of Long-Term Debt
NRC Health (NRC) had Fair Value of Long-Term Debt of $48.74 million as of 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Notes › Debt
us-gaap:LongTermDebtFairValue · last filed 2024-11-08
- 2024-09-30: Long-term Debt, Fair Value $48.74M.
- 2024-06-30: Long-term Debt, Fair Value $32.89M.
- 2024-03-31: Long-term Debt, Fair Value $34.72M.
- 2023-12-31: Long-term Debt, Fair Value $36.40M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2024-09-30 | $48.74M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $32.89M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $34.72M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $36.40M 10-Q · filed 2024-11-08 |
| 2023-09-30 | $18.25M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $19.45M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $20.78M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $21.67M 10-K · filed 2024-02-27 |
| 2022-09-30 | $22.68M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $24.36M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $25.72M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $27.71M 10-K · filed 2023-03-03 |
| 2021-09-30 | $29.11M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $30.30M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $31.43M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $32.94M 10-K · filed 2022-03-04 |
| 2020-09-30 | $34.16M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $35.29M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $35.25M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $35.20M 10-K · filed 2021-03-05 |
| 2019-09-30 | $36.31M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $37.16M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $37.62M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $38.26M 10-K · filed 2020-03-06 |
| 2018-09-30 | $38.93M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $39.81M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $1.07M 10-K · filed 2019-03-08 |
| 2017-09-30 | $1.69M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.10M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $2.72M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $3.53M 10-K · filed 2018-03-14 |
| 2016-09-30 | $3.94M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $4.55M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $5.14M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $5.71M 10-K · filed 2017-03-03 |
| 2015-09-30 | $6.32M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $6.88M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $7.46M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $8.00M 10-K · filed 2016-03-04 |
| 2014-09-30 | $8.54M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $9.11M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $9.63M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $10.16M 10-K · filed 2015-03-04 |
| 2013-09-30 | $10.74M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $11.38M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $12.05M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $12.49M 10-K · filed 2014-03-04 |
| 2012-09-30 | $13.19M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $13.68M 10-Q · filed 2012-08-10 |
| 2011-12-31 | $14.50M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |